Application Information

This drug has been submitted to the FDA under the reference 021205/001.

Names and composition

"TRIZIVIR" is the commercial name of a drug composed of ABACAVIR SULFATE and LAMIVUDINE and ZIDOVUDINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021205/001 TRIZIVIR ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE TABLET/ORAL EQ 300MG BASE and 150MG and 300MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021205/001 TRIZIVIR ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE TABLET/ORAL EQ 300MG BASE and 150MG and 300MG
090309/001 ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL EQ 300MG BASE and 150MG and 300MG
202912/001 ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE TABLET/ORAL EQ 300MG BASE and 150MG and 300MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved